---
title: "HUALAN BIOLOGICAL plans to increase its investment in its affiliated company HUALAN GENETICS by 200 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/247626263.md"
description: "HUALAN BIOLOGICAL announced that it will increase its investment in its affiliated company HUALAN Gene by 200 million yuan. HUALAN Gene currently has a registered capital of 200 million yuan, with HUALAN BIOLOGICAL holding a 40% stake. The gene company plans to raise 500 million yuan, of which 100 million yuan will be used for registered capital and 400 million yuan for capital reserves. After the capital increase, the shareholding ratio of HUALAN BIOLOGICAL and its actual controller Mr. An Kang will remain unchanged"
datetime: "2025-07-08T11:09:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247626263.md)
  - [en](https://longbridge.com/en/news/247626263.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247626263.md)
---

# HUALAN BIOLOGICAL plans to increase its investment in its affiliated company HUALAN GENETICS by 200 million yuan

According to the announcement from HUALAN BIOLOGICAL (002007.SZ), Hualan Gene Engineering Co., Ltd. (hereinafter referred to as "Gene Company") is an associate company of the firm, with a current registered capital of RMB 200 million, of which the company contributed RMB 80 million, accounting for 40% of the registered capital; the actual controller of the company, Mr. An Kang, contributed RMB 120 million, accounting for 60% of the registered capital.

In accordance with production and operational needs, the Gene Company plans to increase its capital by RMB 500 million, of which RMB 100 million will be used to increase the registered capital and RMB 400 million will be used to increase the capital reserve. To this end, the existing shareholders will increase their capital in the Gene Company according to their original contribution ratios. The company plans to increase its capital by RMB 200 million in cash at a ratio of 40%, subscribing to an additional RMB 40 million of registered capital in the Gene Company; Mr. An Kang will increase his capital by RMB 300 million in cash at a ratio of 60%, subscribing to an additional RMB 60 million of registered capital in the Gene Company. After the capital increase is completed, the contribution ratios of the company and Mr. An Kang will remain unchanged

### Related Stocks

- [002007.CN](https://longbridge.com/en/quote/002007.CN.md)

## Related News & Research

- [CEO.CA's Inside the Boardroom: How Viva Gold is Slashing Costs and De-Risking the Tonopah Gold Project in Nevada | VAUCF Stock News](https://longbridge.com/en/news/287236638.md)
- [Possible Bearish Signals With Remgro Insiders Disposing Stock](https://longbridge.com/en/news/287005043.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [The Mercedes AMG GT Coupe Is An Absolute BEAST!](https://longbridge.com/en/news/287260454.md)
- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)